RespireRx Pharmaceuticals Inc (RSPI): Collegeguy, I'm guessing in the $8-12 m...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	87
Posts	33239
Boards Moderated	86
Alias Born	03/22/2005

gfp927z

Re: collegeguy post# 2321

Tuesday, 11/28/2006 5:23:42 PM

Tuesday, November 28, 2006 5:23:42 PM

Collegeguy, I'm guessing in the $8-12 mil range will be raised in the first shelf offering. Combined with the approx $8-10 mil Cortex will already have at year end, that gives a total of $16-22 mil in cash, which should be enough to get Cortex to some type of pharma deal for CX-717/N.Amer. Neurodegenerative, hopefully by mid-'07.

The non-Ampakine in-license idea is another variable, but one would think that that won't happen until the fate of CX-717 is known.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent RSPI News

Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 12:45:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 12:30:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 08:01:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 01:03:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 01:30:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:45:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 01:45:18 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:06:03 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:05:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 01:00:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 12:45:26 PM